The merger and acquisition (M&A) train powered through instability this year, keeping a pace dealmakers worry will not be maintained next year.
Global mergers and acquisitions weathered geopolitical tensions and roiling markets to post US$2.99 trillion in volume this year, a 1.5 percent dip from last year, although still the fifth-best year ever.
The number of deals this year through Friday last week dropped 4.2 percent to 29,015, according to data compiled by Bloomberg. The biggest was United Technologies Corp’s agreement in June to buy Raytheon Co, creating an aerospace and defense player worth more than US$100 billion.
“The current M&A market has proven to be unstoppable,” Goldman Sachs Group Inc cohead of global mergers and acquisitions Dusty Philip said. “Despite spikes in market volatility and macro concerns regarding trade and political uncertainty, we’ve seen a flurry of large-scale M&A transactions in recent weeks.”
The bank’s “backlog is clearly up from the beginning of the year,” he said.
Goldman Sachs remained the top-ranked dealmaker this year, advising on 281 transactions worth US$1 trillion, according to data compiled by Bloomberg.
JPMorgan Chase & Co, neck and neck with Morgan Stanley for the second slot, followed with 258 deals worth US$874 billion. Morgan Stanley advised on 234 deals worth US$821 billion.
While last year they were buoyed by a flush of private equity deals and transactions in the middle-market, this year was propped up by a rush of mega-mergers. The top three investment banks were also helped as turmoil in Europe stung the region’s dealmakers.
Board rooms have plenty to worry about next year: the tumultuous US presidential campaign, the UK’s Brexit deadlines, tariff-fueled trade tensions and regulatory regimes targeting the world’s largest companies.
There are likely to be fewer large deals next year, partly because of regulatory issues, Morgan Stanley’s global head of mergers and acquisitions Robert Kindler said. He expects the number of transactions to be comparable to this year, even as volumes shrink.
“I don’t expect that in anticipation of the election there will be a rush to do deals out of concern with the possibility of a change in administration,” he said. “I don’t think there’s that much of a difference between the current administration and what some of the Democratic candidates are saying.”
Some deal drivers have not let up, such as shareholders pushing for buyout paydays over stock buybacks. As global economic activity grows more subdued, companies seeking growth are fighting over fewer desirable assets.
Private equity firms, flush with an estimated US$1.4 trillion in dry powder, are benefiting from cheap financing and finding partners to buy bigger targets.
The largest this year was the US$14.3 billion buyout of fiber network company Zayo Group Holdings Inc announced in May, in which Stockholm-based private equity firm EQT AB joined Digital Colony Partners.
Several private equity firms have been circling Germany’s Thyssenkrupp AG, which could fetch more than 15 billion euros (US$16.6 billion), people familiar with the matter have said.
Buyout firms have also been eyeing even larger targets such as Walgreens Boots Alliance Inc, the US$52 billion drugstore operator.
While buyout firms are expected to remain very active next year, some of their ambitions could be hampered by tightening credit markets.
“People are going to be hard pressed to add a lot of leverage,” JPMorgan global cohead of mergers and acquisitions Chris Ventresca said.
Alison Harding-Jones, head of M&A for Europe, the Middle East and Africa at Citigroup Inc, expects a busy first half of the year.
“There’s support for strategic deals that are fairly priced — demand for high quality companies is strong across strategics and private equity,” she said.
Healthcare M&A volumes hit an all-time high this year, reaching US$461 billion. Mega deals included Bristol-Myers Squibb Co buying Celgene Corp and AbbVie Inc acquiring Allergan PLC.
Bank of America Corp’s head of healthcare banking for Europe, the Middle East and Africa Christina Dix said pharmaceutical companies would focus on optimizing their portfolios amid drug pricing pressure and US healthcare reform.
Jonathan Davis, an M&A partner at Kirkland & Ellis who advised AbbVie on the Allergan deal, said the deals pipeline is strong, but he is watching whether companies show increased caution next year.
“There are a lot of positive conversations going on, but that is balanced by a few pronounced headwinds, including an upcoming election cycle and associated political and regulatory uncertainty, high valuations and recent choppiness in the credit markets,” he added.
To combat future market swings, companies are using stock to fund deals at the highest level in almost 20 years.
Acquisitions by US companies in which part of the payment is stock have surged 41 percent to US$753 billion, higher than any previous full year since 2000.
Paying in stock, which ties a deal’s risk to the market, would remain a popular option to hard cash, JPMorgan’s head of M&A for North America Anu Aiyengar said.
“When you have a large amount of uncertainty in the world, one way to address that is to do stock-for-stock deals,” she said.
HANDOVER POLICY: Approving the probe means that the new US administration of Donald Trump is likely to have the option to impose trade restrictions on China US President Joe Biden’s administration is set to initiate a trade investigation into Chinese semiconductors in the coming days as part of a push to reduce reliance on a technology that US officials believe poses national security risks. The probe could result in tariffs or other measures to restrict imports on older-model semiconductors and the products containing them, including medical devices, vehicles, smartphones and weaponry, people familiar with the matter said. The investigation examining so-called foundational chips could take months to conclude, meaning that any reaction to the findings would be left to the discretion of US president-elect Donald Trump’s incoming team. Biden
INVESTMENT: Jun Seki, chief strategy officer for Hon Hai’s EV arm, and his team are currently in talks in France with Renault, Nissan’s 36 percent shareholder Hon Hai Precision Industry Co (鴻海精密), the iPhone maker known as Foxconn Technology Group (富士康科技集團) internationally, is in talks with Nissan Motor Co’s biggest shareholder Renault SA about its willingness to sell its shares in the Japanese automaker, the Central News Agency (CNA) said, citing people it did not identify. Nissan and fellow Japanese automaker, Honda Motor Co, are exploring a merger that would create a rival to Toyota Motor Corp in Japan and better position the combined company to face competitive challenges around the world, people familiar with the matter said on Wednesday. However, one potential spanner in the works is
Call it an antidote to fast fashion: Japanese jeans hand-dyed with natural indigo and weaved on a clackety vintage loom, then sold at a premium to global denim connoisseurs. Unlike their mass-produced cousins, the tough garments crafted at the small Momotaro Jeans factory in southwest Japan are designed to be worn for decades, and come with a lifetime repair warranty. On site, Yoshiharu Okamoto gently dips cotton strings into a tub of deep blue liquid, which stains his hands and nails as he repeats the process. The cotton is imported from Zimbabwe, but the natural indigo they use is harvested in Japan —
HON HAI LURKS: The ‘Nikkei’ reported that Foxconn’s interest in Nissan accelerated the Honda-merger effort out of fears it might be taken over by the Taiwanese firm Nissan Motor Co has become the latest buyout target in Japan as it explores a merger with Honda Motor Co and faces an overture from Hon Hai Precision Industry Co (鴻海精密), known as Foxconn Technology Group (富士康科技集團) internationally. Shares in Nissan yesterday jumped 24 percent, the most on record, to hit the daily limit, after the two Japanese automakers acknowledged that talks are ongoing to better position themselves for competitive challenges during a time of upheaval in the global auto industry. Foxconn — a Taipei-based manufacturer of iPhones, which has been investing heavily in factories to build electric vehicles — has also
RSS